[Funding alert] Diagnostics Startup Curelo Secures Funding from IIMA’s CIIE.CO

Curelo, a platform that enables patients to book at-home collection of blood samples along with getting blood reports, secured a $100K grant from IIMA's CIIE.CO.

A mobile team of pharmacy technicians can collect and bring the samples to the lab within 60 minutes of booking on the platform. The platform helps patients find labs based on test accessibility, cost, and processing time.

Read also - [Funding alert] Nawgati Secures Undisclosed Amount in Seed Funding Led by All In Capital

Dr. Arpit Jayswal, Curelo’s Founder and CEO, commented ”We are excited to have CIIE.CO back Curelo. Their conviction reflects the immense potential in our platform and the diagnostic aggregator sector. Our primary focus is scaling nationwide, optimizing user experience, and standardizing sample collection, aiming to serve 1000+ home samples daily by year-end. We are keen to have CIIE.CO support us in this journey with their exceptional sector understanding and network”

In its first ten months of operation, Curelo collaborated with 1350+ labs, handled more than 125,000 orders, and now generates INR 55 Lacs every month with a 30% month throughout month growth.

Read also - IIHMR Startups organized 3rd Edition of the Grand Health Innovation Challenge for Student Innovators to Promote Entrepreneurial Ecosystem in the Healthcare

Mr. Vipul Patel, Partner - Seed Investments at CIIE.CO, said, “The fragmented diagnostic market, commanding an 85% market share, is composed of standalone and hospital-based labs. Whereas, the top four corporate diagnostics chains in India hold a mere 6% share. Arpit’s experience in running a chain of multi-specialty hospitals and diagnostic labs gives him deep insights into the customer pain points. We are excited to partner with the Curelo team and look forward to helping them scale their business.”

About Curelo

India's Curelo is a platform that aggregates diagnostic labs. Dr. Arpit Jayswal, a laparoscopic surgeon, founded Curelo in 2022 with the goal of disrupting the medical diagnostic market by bringing all diagnostic labs onto its online platform and standardizing the patient's home collection of samples procedure.

Read also - [Funding alert] InsuranceDekho Raises $60 Mn in Series B Round